VY-AADC

1 stories · following the connections

Business

Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for VY-AADC for Advanced Parkinson’s Disease

By Nasdaq OMXJan 23, 2018, 12:04 PM UTC